A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ESFT / Ewing sarcoma family of tumors

[Related PubMed/MEDLINE]
Total Number of Papers: 217
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ESFT  (>> Co-occurring Abbreviation)
Long Form:   Ewing sarcoma family of tumors
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Case-control study of paternal occupational exposures and childhoodbone tumours and soft-tissue sarcomas in Great Britain, 1962-2010. ---
2020 Different 18 F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors. 18F-FDG PET, MTV, NAC
2020 Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers. sEVs
2020 International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol. VDC/IE, VIDE
2020 Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review. ES
2020 Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04. IE, PFS, VDC
2020 Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. EFS, OS
2020 Primary Renal Ewing Sarcoma in Children and Young Adults. ---
2020 [Research on Analysis of Final Diagnosis and Prognostic Factors, and Development of New Therapeutic Drugs for Malignant Tumors (Especially Malignant Pediatric Tumors)]. ---
10  2019 Ewing's sarcoma of the lung: A rare case. CT, PET, PNET
11  2019 Extra-skeletal Ewing Sarcoma of the chest wall in a child. CT, ES-EWS
12  2019 Prognostic profiling of the immune cell microenvironment in Ewings Sarcoma Family of Tumors. EFS, HIF-1alpha, OS, TME
13  2018 Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region. FLI-1
14  2018 Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT). IHC, OS, PFS
15  2018 Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors. PBT, VDC-IE
16  2018 Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors. MTAP, OS
17  2018 NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing's sarcoma family of tumors: a case report. NUT
18  2017 A Comparison of Pediatric vs. Adult Patients with the Ewing Sarcoma Family of Tumors. OS, PNET, RT
19  2017 Ewing sarcoma family of tumors in children younger than 10 years of age. OS, RFS
20  2017 Haploidentical hematopoietic cell transplantation for disseminated Ewing sarcoma. GVHD
21  2017 Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors. IHC
22  2017 Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumors. MTV, OS, PFS, TLG
23  2017 Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience. ---
24  2017 Rare adrenal gland incidentaloma: an unusual Ewing's sarcoma family of tumor presentation and literature review. CT
25  2017 Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors. ---
26  2016 Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. IHC, SRCS, SRCT
27  2016 Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review. ELS
28  2016 Initial diagnostic management of pediatric bone tumors. OS
29  2016 Investigational therapies for Ewing sarcoma: a search without a clear finding. ES, mTOR, PARP, VEGF
30  2016 Management of Ewing sarcoma family of tumors: Current scenario and unmet need. ---
31  2016 Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report. VAC/IE
32  2016 Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature. PNETs
33  2016 Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan. OS, PFS
34  2016 Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets. OS
35  2016 Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. CI, EFS, IE, LC, OS, VDC, VTc
36  2016 Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor. OS, PFS
37  2016 Synthetic treatment of intracranial peripheral primitive neuroectodermal tumor with multiple metastasis: a case report. ES, pPNET
38  2016 The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. SCO
39  2015 A Case of Renal Primitive Neuroectodermal Tumor Confirmed by Fluorescence in situ Hybridization. PNET
40  2015 Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol. ---
41  2015 Histological diversity and clinical characteristics of Ewing sarcoma family of tumors in children: A series from a tertiary care center in South India. FISH, PNET
42  2015 Late recurrence of a tumor of Ewing's sarcoma family of tumors: report of a case. EWS, PNET
43  2015 Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports. FAERS
44  2015 Prognostic factors in head and neck Ewing sarcoma family of tumors. EFS, NACT, OS, WBC
45  2015 Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family Tumors. LC, OS, RT
46  2015 Targeted therapies for advanced Ewing sarcoma family of tumors. ---
47  2015 [Combined therapy for children and adolescents with Ewing tumors (a 25-year experience)]. ---
48  2014 A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. SRCSs
49  2014 A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors. CR, DI, ORR, PFS, PRs
50  2014 Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol. EFS, LCR, NACT
51  2014 Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection. MRT
52  2014 Lower extremity reconstruction after limb-sparing sarcoma resection of the proximal tibia in the pediatric population: case series, with algorithm. LSS, OS
53  2014 Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors. ---
54  2014 Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family. AI, OS, PI, RFS
55  2014 Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey. ICE, IE
56  2014 Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma. ---
57  2014 Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma. CSC
58  2014 The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. GLI1, PI
59  2013 Adult primary pulmonary primitive neuroectodermal tumor: molecular features and translational opportunities. PNET
60  2013 DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumors. CCSK, CMN, NK, RTK
61  2013 Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing's sarcoma family of tumors. CIRT, HDC
62  2013 Ewing sarcoma of the bone in children under 6 years of age. AIEOP, OS, PFS
63  2013 Ewing's sarcoma with an uncommon clinical course: A case report. ---
64  2013 Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. NB, RMS
65  2013 Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases. RMS, WLI
66  2013 Latent adrenal Ewing sarcoma family of tumors: A case report. ---
67  2013 Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy. IGF, mTOR, PARP
68  2013 Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma. ---
69  2013 Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. ---
70  2013 Role of extracorporeal irradiation in malignant bone tumors. ECI, MBT, MSTS, OS
71  2013 Superficial small round-cell tumors with special reference to the Ewing's sarcoma family of tumors and the spectrum of differential diagnosis. ---
72  2012 A Novel Role of IGF1 in Apo2L/TRAIL-Mediated Apoptosis of Ewing Tumor Cells. Apo2L, Cer, CerS, IGF-1, IGF1R, XIAP
73  2012 A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. CSC, miRNAs
74  2012 Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience. EFS, SJCRH
75  2012 Diagnostic accuracy of ⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. CI, FDG, PET, PET/CT, ROC
76  2012 Ewing's sarcoma family of tumors originating in the main bronchus. PNET
77  2012 EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors. CTL
78  2012 Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. HLA
79  2012 PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. ---
80  2012 Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma. ARMS, NPT, PCa
81  2012 PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma. EWS
82  2012 Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection. chNKG2D, NKG2DLs
83  2012 Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas. allo-HSCT, OS
84  2012 STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of Tumors In Vitro. STAT3
85  2011 A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. ---
86  2011 Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience. OS, PET, SUV2
87  2011 Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors. OS
88  2011 Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. ---
89  2011 Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy. AIF, DPPs, FAP, NPY, Y5Rs
90  2011 Epithelial marker expression does not rule out a diagnosis of Ewing's sarcoma family of tumours. CEA, CK, EMA
91  2011 Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. ---
92  2011 Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma. ---
93  2011 Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia. ---
94  2011 Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. miRNA, MSC
95  2011 Modeling initiation of Ewing sarcoma in human neural crest cells. hNC-MSC, hNCSC, MSC
96  2011 Morphometric analysis of DNA ploidy and nuclear cell cycle regulators in Ewing's sarcoma/primitive neuroectodermal tumor. SRCTs
97  2011 Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. ---
98  2011 Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour. ---
99  2011 Potential role of FDG PET imaging in predicting metastatic potential and assessment of therapeutic response to neoadjuvant chemotherapy in Ewing sarcoma family of tumors. NACT
100  2011 Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors. HLA, mAb